Search research articles
Contact Us
Filters
Showing results (121-130 of 226) with videos related to
Page
of 23
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 15, 2010
Editor's choice: Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Guérin used for immunotherapy in bladder cancer
Matthew R Watts, Peter C Taylor, Vitali Sintchenko, et al.
Journal of the American College of Cardiology
|
December 4, 2003
Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure
John S Rumsfeld, Edward Havranek, Frederick A Masoudi, et al.
Trials
|
April 15, 2021
Bedside Ultrasound Conducted in Kids with distal upper Limb fractures in the Emergency Department (BUCKLED): a protocol for an open-label non-inferiority diagnostic randomised controlled trial
Peter J Snelling, Gerben Keijzers, Joshua Byrnes, et al.
The New England Journal of Medicine
|
May 31, 2023
Ultrasonography or Radiography for Suspected Pediatric Distal Forearm Fractures
Peter J Snelling, Philip Jones, David Bade, et al.
Journal of Pharmacological and Toxicological Methods
|
February 6, 2010
PISA, a novel pharmacodynamic assay for assessing poly(ADP-ribose) polymerase (PARP) activity in situ
Laura S Lubbers, Blake A Rowe, Lisa M Hodge, et al.
Contemporary Clinical Trials
|
November 18, 2021
Patient representativeness of a peripheral artery disease cohort in a randomized control trial versus a real-world cohort: The CLEVER trial versus the PORTRAIT registry
Lindsey E Scierka, Qurat-Ul-Ain Jelani, Kim G Smolderen, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 24, 2008
Optimization of a series of potent and selective ketone histone deacetylase inhibitors
Giovanna Pescatore, Olaf Kinzel, Barbara Attenni, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 25, 2009
Identification and SAR of novel pyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1)
Giovanna Pescatore, Danila Branca, Fabrizio Fiore, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 22, 2008
2-Trifluoroacetylthiophene oxadiazoles as potent and selective class II human histone deacetylase inhibitors
Ester Muraglia, Sergio Altamura, Danila Branca, et al.
Journal of Medicinal Chemistry
|
March 29, 2008
A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo
Philip Jones, Sergio Altamura, Raffaele De Francesco, et al.
Page
of 23
Search research articles
Search
Showing results (121-130 of 226) with videos related to
Sort By:
Page
of 23
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 15, 2010
Editor's choice: Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Guérin used for immunotherapy in bladder cancer
Matthew R Watts, Peter C Taylor, Vitali Sintchenko, et al.
Journal of the American College of Cardiology
|
December 4, 2003
Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure
John S Rumsfeld, Edward Havranek, Frederick A Masoudi, et al.
Trials
|
April 15, 2021
Bedside Ultrasound Conducted in Kids with distal upper Limb fractures in the Emergency Department (BUCKLED): a protocol for an open-label non-inferiority diagnostic randomised controlled trial
Peter J Snelling, Gerben Keijzers, Joshua Byrnes, et al.
The New England Journal of Medicine
|
May 31, 2023
Ultrasonography or Radiography for Suspected Pediatric Distal Forearm Fractures
Peter J Snelling, Philip Jones, David Bade, et al.
Journal of Pharmacological and Toxicological Methods
|
February 6, 2010
PISA, a novel pharmacodynamic assay for assessing poly(ADP-ribose) polymerase (PARP) activity in situ
Laura S Lubbers, Blake A Rowe, Lisa M Hodge, et al.
Contemporary Clinical Trials
|
November 18, 2021
Patient representativeness of a peripheral artery disease cohort in a randomized control trial versus a real-world cohort: The CLEVER trial versus the PORTRAIT registry
Lindsey E Scierka, Qurat-Ul-Ain Jelani, Kim G Smolderen, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 24, 2008
Optimization of a series of potent and selective ketone histone deacetylase inhibitors
Giovanna Pescatore, Olaf Kinzel, Barbara Attenni, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 25, 2009
Identification and SAR of novel pyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1)
Giovanna Pescatore, Danila Branca, Fabrizio Fiore, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 22, 2008
2-Trifluoroacetylthiophene oxadiazoles as potent and selective class II human histone deacetylase inhibitors
Ester Muraglia, Sergio Altamura, Danila Branca, et al.
Journal of Medicinal Chemistry
|
March 29, 2008
A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo
Philip Jones, Sergio Altamura, Raffaele De Francesco, et al.
Page
of 23